135 related articles for article (PubMed ID: 37562607)
1. Diketo acid inhibitors of nsp13 of SARS-CoV-2 block viral replication.
Corona A; Madia VN; De Santis R; Manelfi C; Emmolo R; Ialongo D; Patacchini E; Messore A; Amatore D; Faggioni G; Artico M; Iaconis D; Talarico C; Di Santo R; Lista F; Costi R; Tramontano E
Antiviral Res; 2023 Sep; 217():105697. PubMed ID: 37562607
[TBL] [Abstract][Full Text] [Related]
2. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
Freidel MR; Armen RS
PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
[TBL] [Abstract][Full Text] [Related]
3. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.
Grimes SL; Choi YJ; Banerjee A; Small G; Anderson-Daniels J; Gribble J; Pruijssers AJ; Agostini ML; Abu-Shmais A; Lu X; Darst SA; Campbell E; Denison MR
mBio; 2023 Aug; 14(4):e0106023. PubMed ID: 37338298
[TBL] [Abstract][Full Text] [Related]
4. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X
Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504
[TBL] [Abstract][Full Text] [Related]
5. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
[TBL] [Abstract][Full Text] [Related]
6. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
Li A; Zhang B; Zhao K; Yin Z; Teng Y; Zhang L; Xu Z; Liang K; Cheng X; Xia Y
J Virol; 2023 Jul; 97(7):e0051223. PubMed ID: 37347173
[TBL] [Abstract][Full Text] [Related]
8. The stalk domain of SARS-CoV-2 NSP13 is essential for its helicase activity.
Yue K; Yao B; Shi Y; Yang Y; Qian Z; Ci Y; Shi L
Biochem Biophys Res Commun; 2022 Apr; 601():129-136. PubMed ID: 35245742
[TBL] [Abstract][Full Text] [Related]
9. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
[TBL] [Abstract][Full Text] [Related]
10. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
[TBL] [Abstract][Full Text] [Related]
11. The Coronavirus helicase in replication.
Grimes SL; Denison MR
Virus Res; 2024 Aug; 346():199401. PubMed ID: 38796132
[TBL] [Abstract][Full Text] [Related]
12. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors.
Yazdi AK; Pakarian P; Perveen S; Hajian T; Santhakumar V; Bolotokova A; Li F; Vedadi M
ACS Infect Dis; 2022 Aug; 8(8):1533-1542. PubMed ID: 35822715
[TBL] [Abstract][Full Text] [Related]
13. Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro.
Lu L; Peng Y; Yao H; Wang Y; Li J; Yang Y; Lin Z
Antiviral Res; 2022 Oct; 206():105389. PubMed ID: 35985407
[TBL] [Abstract][Full Text] [Related]
14. Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase.
Weber R; McCullagh M
J Phys Chem B; 2021 Aug; 125(31):8787-8796. PubMed ID: 34328740
[TBL] [Abstract][Full Text] [Related]
15. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
Habtemariam S; Nabavi SF; Banach M; Berindan-Neagoe I; Sarkar K; Sil PC; Nabavi SM
Arch Med Res; 2020 Oct; 51(7):733-735. PubMed ID: 32536457
[TBL] [Abstract][Full Text] [Related]
16. Biochemical analysis of SARS-CoV-2 Nsp13 helicase implicated in COVID-19 and factors that regulate its catalytic functions.
Sommers JA; Loftus LN; Jones MP; Lee RA; Haren CE; Dumm AJ; Brosh RM
J Biol Chem; 2023 Mar; 299(3):102980. PubMed ID: 36739951
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.
Spratt AN; Gallazzi F; Quinn TP; Lorson CL; Sönnerborg A; Singh K
Expert Opin Ther Pat; 2021 Apr; 31(4):339-350. PubMed ID: 33593200
[No Abstract] [Full Text] [Related]
18. Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication-transcription complex.
Chen J; Wang Q; Malone B; Llewellyn E; Pechersky Y; Maruthi K; Eng ET; Perry JK; Campbell EA; Shaw DE; Darst SA
Nat Struct Mol Biol; 2022 Mar; 29(3):250-260. PubMed ID: 35260847
[TBL] [Abstract][Full Text] [Related]
19. Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase.
Mickolajczyk KJ; Shelton PMM; Grasso M; Cao X; Warrington SE; Aher A; Liu S; Kapoor TM
Biophys J; 2021 Mar; 120(6):1020-1030. PubMed ID: 33340543
[TBL] [Abstract][Full Text] [Related]
20. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]